Fosfructose

DB13863InvestigationalSmall molecule

Fosfructose is a phosphorylated form of fructose indicated in the treatment of hypophosphatemia. A medication used to treat low levels of phosphorous in the body.

Chemical structure of Fosfructose
Mechanism
Curator reviewed
Formula / weight
C6H14O12P2 · 340.1157 g/mol (avg)
Also known as
Fructose 1,6-bisphosphate · Fructose 1,6-diphosphate · Fructose-1,6-diphosphate · Harden-young ester

Resolves to

Compound
UNIIM7522JYX1HCAS488-69-7ChEMBLCHEMBL1235112ChEBI16905
Clinical / RWD
RxNorm2119172ATCC01EB07
Structure
InChIKeyXPYBSIWDXQFNMH-UYFOZJQFSA-NSMILES[H][C@@](O)(COP(O)(O)=O)[C@@]([H])(O)[C@]([H])(O)C(=O)COP(O)(O)=O
Targets
P14618PKMP0A6F3glpK

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
152Drug interactionsStructured to mechanism, not free text
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fosfructose, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In